| Literature DB >> 22682537 |
Jong Suk Park1, Min Ho Cho, Chul Woo Ahn, Kyung Rae Kim, Kap Bum Huh.
Abstract
BACKGROUND: The relationship between body composition parameters such as thigh and calf circumference and insulin resistance or atherosclerosis in type 2 diabetes is poorly understood. The aim of this study was to investigate the relationship between insulin resistance, atherosclerosis, and thigh and calf circumference in patients with type 2 diabetes.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22682537 PMCID: PMC3444381 DOI: 10.1186/1475-2840-11-62
Source DB: PubMed Journal: Cardiovasc Diabetol ISSN: 1475-2840 Impact factor: 9.951
Baseline clinical characteristics of subjects
| N | 2,323 | 2,104 |
| Age (years) | 55.75 ± 11.63 | 56.50 ± 11.67 |
| Duration of diabetes (years) | 6.67 ± 6.99 | 6.54 ± 6.20 |
| SBP (mmHg) | 134.02 ± 17.03 | 136.84 ± 18.87 |
| DBP (mmHg) | 87.86 ± 11.25 | 85.28 ± 11.32 |
| Weight (kg) | 70.89 ± 10.20 | 59.34 ± 9.08 |
| BMI (kg/m2) | 24.57 ± 3.25 | 24.56 ± 3.34 |
| WC (cm) | 86.23 ± 7.74 | 79.41 ± 8.31 |
| Smoking (n, %) | 354 (15.2%) | 32 (1.5%) |
| Antihypertensive medication, N (%) | 720 (30.9) | 694 (32.9) |
| Antidyslipidemic medication, N (%) | 464 (19.9) | 487 (23.1) |
| Antidiabetic medication | | |
| Sulfonylureas | 1441 (62.0) | 1328 (63.1) |
| Metformin | 973 (41.8) | 1032 (49.0) |
| AGIs | 246 (10.6) | 231 (10.9) |
| FPG (mmol/L) | 8.25 ± 2.69 | 7.91 ± 2.69 |
| TC (mmol/L) | 4.99 ± 1.02 | 5.27 ± 1.07 |
| TG (mmol/L) | 1.55 (1.00-3.19) | 1.38 (1.00-2.42) |
| LDL-C (mmol/L) | 2.96 ± 0.88 | 3.16 ± 0.96 |
| HDL-C (mmol/L) | 1.23 ± 0.30 | 1.35 ± 0.34 |
| Insulin (μIU/mL) | 6.9 (5.1-9.4) | 7.6 (5.6-10.2) |
| HOMA-IR | 2.79 ± 1.73 | 2.94 ± 1.97 |
| HbA1c (%) | 8.37 ± 2.00 | 8.32 ± 1.85 |
| VAT (mm) | 48.39 ± 17.23 | 39.94 ± 16.45 |
| Calf circumference (mm) | 35.96 ± 3.19 | 33.22 ± 2.64 |
| Thigh circumference (mm) | 45.19 ± 4.03 | 43.88 ± 3.99 |
| Mean IMT(mm) | 0.83 ± 0.19 | 0.80 ± 0.18 |
| Kitt (%/min) | 2.28 ± 0.96 | 2.31 ± 0.94 |
Data are mean ± SD or proportion (%). Data for TG and insulin were skewed distribution, and were presented as the median (interquartile range). SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; WC, waist circumference; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; Homeostasis Model Assessment of Insulin Resistance, HOMA-IR; HbA1c, hemoglobin A1c; VAT, visceral adipose thickness; IMT, intima media thickness; Kitt, rate constant for plasma glucose disappearance.
Correlation between insulin sensitivity index (Kitt), IMT and other variables
| | ||||
|---|---|---|---|---|
| Age | −0.051** | −0.139** | 0.410** | 0.369** |
| Duration of diabetes | −0.064** | −0.060* | 0.212** | 0.147** |
| SBP | −0.125** | −0.164** | 0.196** | 0.220** |
| DBP | −0.126** | −0.104** | 0.005 | 0.039* |
| Weight | −0.159** | −0.192** | 0.064** | 0.044* |
| BMI | −0.196** | −0.216** | 0.029 | 0.064** |
| WC | −0.277** | −0.300** | 0.063** | 0.100** |
| Smoking habits | −0.038 | 0.017 | 0.034 | 0.009 |
| FPG | −0.351** | −0.370** | 0.025 | 0.006 |
| TC | −0.140** | −0.138** | 0.042* | 0.071** |
| TG | −0.276** | −0.294** | 0.041* | 0.074* |
| LDL-C | −0.052** | −0.036* | 0.080** | 0.071** |
| HDL-C | 0.103** | 0.112** | −0.024* | −0.037* |
| Insulin | −0.215** | −0.218** | 0.022 | 0.072** |
| HOMA-IR | −0.347** | −0.367** | 0.050** | 0.053** |
| HbA1c | −0.286** | −0.195** | 0.073** | 0.016 |
| VAT | −0.284** | −0.313** | 0.057** | 0.102** |
| Weight adjusted calf circumference | 0.211** | 0.258** | −0.027 | −0.173** |
| Weight adjusted thigh circumference | 0.244** | 0.279** | −0.102* | −0.170** |
| Mean IMT | −0.062** | −0.092** | | |
| Kitt | −0.062** | −0.092** | ||
* P < 0.05, **P <0.01.
SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; WC, waist circumference; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; Homeostasis Model Assessment of Insulin Resistance, HOMA-IR; HbA1c, hemoglobin A1c; VAT, visceral adipose thickness; IMT, intima media thickness; Kitt, rate constant for plasma glucose disappearance.
Figure 1The relationship between insulin resistance and thigh and calf circumference in men (A) and women (B). The insulin sensitivity index (Kitt) was significantly correlated with weight adjusted thigh and calf circumference in both men and women (P < 0.01).
Figure 2The relationship between intima media thickness and thigh and calf circumference in men (A) and women (B). Carotid IMT differed among the four groups of thigh and calf circumference (P <0.05 vs. first tertile)
Multiple stepwise regression analysis showing variables independently associated with insulin sensitivity index (Kitt)
| WC | −0.182** | −0.199** |
| FPG | −0.286** | −0.230** |
| TG | −0.110** | −0.139** |
| Insulin | −0.178** | −0.172** |
| HbA1c | −0.123** | −0.156** |
| VAT | −0.136** | −0.145** |
| Weight adjusted thigh circumference | 0.128** | 0.141** |
* P < 0.05, **P <0.01.
WC, waist circumference; FPG, fasting plasma glucose; TG, triglyceride; HbA1c, hemoglobin A1c;VAT, visceral adipose thickness; Kitt, rate constant for plasma glucose disappearance.
Multiple stepwise regression analysis showing variables independently associated with IMT
| Age | 0.351** | 0.347** |
| SBP | 0.143** | 0.151** |
| Duration of diabetes | 0.094** | 0.067** |
| LDL-C | 0.108** | 0.085** |
| VAT | 0.073** | 0.103** |
| Weight adjusted thigh circumference | −0.092* | −0.124** |
* P < 0.05, **P <0.01.
SBP, systolic blood pressure; LDL-C, low-density lipoprotein cholesterol; VAT, visceral adipose thickness; IMT, intima media thickness.
The Odds ratios (95% CI) for carotid atherosclerosis according to thigh circumference quartiles
| Men | Quartile 1 | 1.59* (1.00-2.35) | 1.46* (0.98-2.27) |
| Quartile 2 | 1.36* (0.98-1.91) | 1.35* (0.99-1.93) | |
| Quartile 3 | 1.33* (0.95-1.88) | 1.30* (0.93-1.64) | |
| Quartile 4 | 1 | 1 | |
| Women | Quartile 1 | 2.37** (1.57-3.55) | 1.86** (1.16-3.05) |
| Quartile 2 | 1.79** (1.17-2.73) | 1.55** (0.95-2.32) | |
| Quartile 3 | 1.41* (0.98-2.13) | 1.33* (0.82-1.89) | |
| Quartile 4 | 1 | 1 |
* P < 0.05, ** P <0.01.
a Adjusted for age, duration of diabetes, smoking status, BMI, blood pressure, lipid, kitt, WC, VAT and treatment medications.